PAVmed (PAVM) Income from Non-Controlling Interests (2018 - 2025)
PAVmed's (PAVM) quarterly Income from Non-Controlling Interests came in at -$1.5 million in Q4 2025, down 416.96% year-on-year from $471360.3 in Q4 2024, and down 137.9% quarter-over-quarter from -$628000.0 in Q3 2025.
PAVmed (PAVM) Income from Non-Controlling Interests (2018 - 2025) Analysis & Trends
PAVmed's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at -$1.5 million for Q4 2025.
- On a quarterly basis, Income from Non-Controlling Interests fell 416.96% year-over-year to -$1.5 million in Q4 2025; TTM through Dec 2025 was -$2.9 million, a 74.02% increase from a year earlier, with the FY2025 full-year figure at -$2.9 million, up 74.74% from the prior year.
- Income from Non-Controlling Interests fell to -$1.5 million in Q4 2025 per PAVM's latest filing, from -$628000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$289000.0 in Q4 2024 and bottomed at -$4.3 million in Q1 2023.
- The 5-year median for Income from Non-Controlling Interests is -$2.8 million (2022), against an average of -$2.4 million.
- Across the five-year window, Income from Non-Controlling Interests soared 91.43% in 2024 and slumped 416.96% in 2025, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at -$2.5 million in 2021, then sank by 67.09% to -$4.1 million in 2022, then rose by 18.0% to -$3.4 million in 2023, then surged by 91.43% to -$289000.0 in 2024, then slumped by 416.96% to -$1.5 million in 2025.
- Per Business Quant, the three latest PAVM Income from Non-Controlling Interests figures stand at -$1.5 million (Q4 2025), -$628000.0 (Q3 2025), and -$403000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | -5.85 Mn |
| 10 | PAVmed | 10.85 Mn | 9.31 Mn | -4,000.00 | -1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.49 Mn |
| Sep 30, 2025 | -628,000.00 |
| Jun 30, 2025 | -403,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | -289,000.00 |
| Jun 30, 2024 | -4.09 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | -3.37 Mn |
| Sep 30, 2023 | -4.08 Mn |
| Jun 30, 2023 | -3.36 Mn |
| Mar 31, 2023 | -4.28 Mn |
| Dec 31, 2022 | -4.11 Mn |
| Sep 30, 2022 | -3.81 Mn |
| Jun 30, 2022 | -3.58 Mn |
| Mar 31, 2022 | -2.76 Mn |
| Dec 31, 2021 | -2.46 Mn |
| Sep 30, 2021 | -1.44 Mn |
| Jun 30, 2021 | -1.20 Mn |
| Mar 31, 2021 | -679,000.00 |
| Dec 31, 2020 | -519,000.00 |